Stay updated on XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Sign up to get notified when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.

Latest updates to the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page
- Check3 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 with removal of the 'Back to Top' link; no substantive content changes detected.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has been updated to include a new facility name and location in St. Louis, Missouri, along with a range of medical terms related to plasma cell myeloma and stem cell transplantation. Several previous terms and references have been removed, indicating a shift in focus towards specific therapies and treatments.SummaryDifference7%
- Check25 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
Stay in the know with updates to XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.